Clinical trial Recruiting at 1 site Observational Ages 18 to 45

Evaluating a deep learning model for selecting implantable collamer lenses using eye images

Official title: Diagnostic Efficacy of Deep Neural Network Algorithm Based on Preoperative Scheimpflug-based Anterior Segment Image for Implantable Collamer Lens Selection and Prediction

Run by Second Affiliated Hospital of Nanchang University · NCT06669728 · Data updated 2026-11-12

This study is testing a new computer program that uses eye images to help doctors choose the best lens for people with nearsightedness.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexAll
Enrollment326 (estimated)
SponsorSecond Affiliated Hospital of Nanchang University
Academic / other
Locations1 site (Nanchang, Jiangxi)
StatusRecruiting
StartedJanuary 2, 2021
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedApril 24, 2026
Trial IDNCT06669728 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18-45 with myopia and stable vision parameters.

Probably not a fit

Patients with a history of corneal refractive surgery or those with systemic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the diagnostic efficacy of a deep learning network model in selecting and predicting the appropriate implantable collamer lens (ICL) for myopia correction. By utilizing eye images, the study seeks to optimize the selection process for ICL design, which is often complicated by varying biological parameters. The research will be conducted across multiple centers and aims to enhance the accuracy, safety, and predictability of ICL implantation, ultimately assisting physicians in their decision-making process.

Why it matters

Potential benefit: If successful, this study could significantly improve the precision of ICL selection, leading to better surgical outcomes for patients with myopia.

How similar studies have gone: While the use of deep learning in medical diagnostics is gaining traction, this specific application for ICL selection is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged 18-45 years ;
2. Myopia, with or without astigmatism, annual diopter change ≤ 0.50 D for 2 consecutive years ;
3. Anterior chamber depth ≥ 2.80 mm ;
4. Corneal endothelial cell count ≥ 2000 / mm2, stable cell morphology ;
5. There were no other ocular diseases that significantly affected vision and / or systemic organic lesions that affected surgical recovery.

Exclusion Criteria:

1. There were no other ocular diseases that significantly affected vision and / or systemic organic lesions that affected surgical recovery;
2. Have a history of corneal refractive surgery or intraocular surgery ;
3. Corneal endothelial cell count is low ;
4. Those with systemic diseases ;
5. Lactating or pregnant women.

Where it's running

  • The Second Affiliated Hospital of Nanchang University
    Nanchang, Jiangxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.